Filter
3388
Text search:
efficacy
Featured
Recommendations
359
New Publications
736
Language
Document type
No document type
1684
Guidelines
663
Studies & Reports
537
Manuals
185
Strategic & Response Plan
110
Fact sheets
95
Training Material
54
Situation Updates
19
Resource Platforms
17
Infographics
12
Videos
5
Brochures
4
Online Courses
1
Countries / Regions
Global
152
India
142
South Africa
86
Kenya
80
Uganda
64
Ethiopia
60
Western and Central Europe
55
Nigeria
54
Tanzania
52
Sierra Leone
51
Latin America and the Carribbean
47
Africa
47
Liberia
46
Zambia
43
Malawi
40
Nepal
39
Ghana
36
Rwanda
36
Bangladesh
31
Russia
29
Eastern Europe
27
Zimbabwe
25
Congo, Democratic Republic of
23
Philippines
23
Myanmar / Burma
23
Indonesia
22
Namibia
22
Brazil
22
Ukraine
22
South–East Asia Region
22
East and Southern Africa
21
Senegal
20
West and Central Africa
19
Mozambique
18
Lesotho
16
Germany
15
Syria
15
Cambodia
15
Guinea
14
Botswana
14
Asia
14
Burkina Faso
13
Pakistan
13
Middle East and North Africa
13
Cameroon
12
South Sudan
11
Eswatini/ Swaziland
10
Argentina
9
Laos
9
Vietnam
9
Haiti
8
Sudan
8
Thailand
7
Peru
7
Sri Lanka
7
Western Pacific Region
7
Eastern Europe and Central Asia
7
Mali
6
USA
6
Jordan
6
Afghanistan
6
Yemen
6
Paraguay
6
North America
6
Côte d’Ivoire / Ivory Coast
5
Somalia
5
China
5
Angola
5
Chile
5
United Kingdom
5
Iraq
4
Lebanon
4
Chad
4
Colombia
4
Ecuador
4
Venezuela
4
Tajikistan
4
Iran
4
Georgia
4
Guinea-Bissau
3
Benin
3
Bhutan
3
Morocco
2
Niger
2
Turkey
2
Papua New Guinea
2
Central African Republic
2
North Macedonia
2
Honduras
2
Mexico
2
Albania
2
Armenia
2
Gabon
2
Tunisia
2
Spain
2
Saudi Arabia
1
Togo
1
Egypt
1
Gambia
1
Mauritania
1
Ireland
1
Singapore
1
Dominican Republic
1
Burundi
1
El Salvador
1
Bolivia
1
Greece
1
Libya
1
Guatemala
1
Madagascar
1
Nicaragua
1
Fiji
1
Djibouti
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Romania
1
Australia
1
Denmark
1
Belgium
1
France
1
Mauritius
1
Belarus
1
Belize
1
Costa Rica
1
Guyana
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1100
Clinical Guidelines
357
Public Health
222
Women & Child Health
153
Key Resources
118
Capacity Building
54
Pharmacy & Technologies
44
Toolboxes
COVID-19
367
Mental Health
327
HIV
306
TB
198
NTDs
177
AMR
155
Pharmacy
121
Malaria
119
Ebola & Marburg
92
NCDs
75
Caregiver
65
Disability
59
Rapid Response
59
Planetary Health
59
Refugee
31
2.0 Rapid Response
26
Cholera
24
Global Health Education
22
Conflict
21
Zika
19
Health Financing Toolbox
18
Polio
16
Natural Hazards
13
Specific Hazards
8
Social Ethics
7
Research Article
BMC Infectious Diseases 2014, 14:91/1471-2334/14/91
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita
...
Lancet Infectious Disease Volume 24, Issue 4p386-394April 2024
the Lancet : Published Online July 31, 2015 http://dx.doi.org/10.1016/S0140-6736(15)61117-5
Preventive chemotherapy with praziquantel (PZQ) is the cornerstone of schistosomiasis control. However, a single dose of PZQ (40 mg/kg) does not cure all infections. Repeated doses of PZQ at short intervals might increase efficacy in terms of cure r
...
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
n this study, low-dose azithromycin did not meet the prespecified non-inferiority margin compared with standard-dose azithromycin in achieving clinical and serological cure in PCR-confirmed active yaws. Only a single participant (with presumed latent yaws) had definitive serological failure. This wo
...
14 July 2021 This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
COVID-19 vaccines have proven to be safe,
...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies o
...
Chemoprevention is the use of medicines, either alone or in combination, to prevent malaria infection and its consequences. This publication provides standardized approaches for monitoring and evaluating the efficacy of medicines used for intermitte
...
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
An example of integration of research into epidemic response.
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Lancet 2024; 403: 533–44
R21/Matrix-M was well tolerated and offered high efficacy against clinical malaria in African children. This
low-cost, high-efficacy vaccine is already licensed by sever
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4